Jisandai (Bingtongsha) purchasing methods and purchasing channels

Epclusa (Epclusa) is a drug used to treat chronic hepatitis C (Hepatitis C). Chronic hepatitis C is a liver inflammation caused by hepatitis C virus (HCV) infection. If not treated in time, it may lead to severe liver function damage, and even serious consequences such as cirrhosis and liver cancer. Gilead Sciences is an oral drug developed and launched on the market by the American pharmaceutical company Gilead Sciences .

Jisandai (Bingtonsha) has been officially sold in China and has also been included in the medical insurance system. This means that domestic patients can purchase directly without looking far. The price is about two to three thousand yuan. Of course, for the specific amount and medical insurance reimbursement details, it is recommended that you consult the local hospital pharmacy for detailed consultation.

In addition, foreignJisandai (Bintongsha) generic drugs, especially the versions produced in Bangladesh and India, are relatively affordable, ranging from a few hundred to more than a thousand yuan, and their pharmaceutical ingredients are basically the same as our domestic original drugs.

The main ingredients of Jisanda (Bingtonsa) are Sofosbuvir (Sofosbuvir) and velpatasvir (Velpatasvir). Sofosbuvir is a nucleoside reverse transcriptase inhibitor that blocks the synthesis of ribonucleic acid (RNA) required for viral replication. Vikastatin is an NS5A inhibitor that blocks key steps in the infection process. The combination of these two ingredients makes Jisandai (Bingtonsha) highly effective against a variety of hepatitis C virus strains, including HCV genotypes 1 to 6 infections.

Compared with traditional hepatitis C treatment methods, Jisandai (Bingtonsha) has many advantages. First, it is an oral medication that patients can take at home without having to go to a hospital or clinic for injections. Secondly, the treatment course of Jisandai (Bingtonsha) is relatively short, usually 12weeks, and durable virologic cure is achieved in the majority of patients, with high cure rates even in those who have previously received other treatments without success. In addition, Gsanda (Bingtonsa) has relatively few side effects and is well tolerated by most patients.